Menu
Search
|

Menu

Close
X

Avadel Pharmaceuticals PLC AVDL.OQ (NASDAQ Stock Exchange Global Market)

2.16 USD
+0.03 (+1.17%)
As of Sep 13
Previous Close 2.14
Open 2.14
Volume 20,893
3m Avg Volume 65,562
Today’s High 2.17
Today’s Low 2.10
52 Week High 4.86
52 Week Low 1.03
Shares Outstanding (mil) 37.36
Market Capitalization (mil) 92.27
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY19
16
FY18
103
FY17
173
FY16
150
EPS (USD)
FY19
-0.349
FY18
-2.568
FY17
1.512
FY16
-1.001
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.85
Price to Sales (TTM)
vs sector
1.07
7.90
Price to Book (MRQ)
vs sector
--
4.38
Price to Cash Flow (TTM)
vs sector
--
23.70
Total Debt to Equity (MRQ)
vs sector
--
17.64
LT Debt to Equity (MRQ)
vs sector
--
12.61
Return on Investment (TTM)
vs sector
-47.36
12.69
Return on Equity (TTM)
vs sector
-248.76
17.13

EXECUTIVE LEADERSHIP

Gregory Divis
Chief Executive Officer, Chief Operating Officer, Executive Vice President, Director, Since 2019
Salary: --
Bonus: --
Michael Kanan
Senior Vice President, Chief Financial Officer, Since 2015
Salary: $325,000.00
Bonus: --
Phillandas Thompson
Senior Vice President, General Counsel, Corporate Secretary, Since 2013
Salary: $297,052.00
Bonus: --
Sandra Hatten
Senior Vice President - Quality and Regulatory Affairs, Since 2015
Salary: $297,840.00
Bonus: --
Dhiren D'Silva
Vice President - Irish and European Operations, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

Block 10-1 Blanchardstown Corpor
Ballycoolin
DUBLIN     15

Phone: +3531.4851200

Avadel Pharmaceuticals, PLC is a specialty pharmaceutical company. The Company offers various drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. The Company offers its products in various categories, including hospital, including Bloxiverz, Vazculep and Akovaz, and pediatrics, including Karbinal ER, Cefaclor for Oral Suspension, AcipHex Sprinkle and Flexichamber. Bloxiverz is a drug used intravenously in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Vazculep is used to treat clinically hypotension resulting primarily from vasodilation in the setting of anesthesia. Akovaz is indicated to treat clinically hypotension in the setting of anesthesia. Cefaclor is indicated for the treatment of otitis media, lower respiratory infections, pharyngitis and tonsillitis, urinary tract infections, and skin and skin structure infections, caused by susceptible organisms.

SPONSORED STORIES